 Bloomberg | Afinitor (Everolimus) Combo For Breast Cancer Approved By FDA Medical News Today The FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor positive, HER2-negative breast cancer. The FDA (Food and Drug Administration) says the ... Novartis' breast cancer drug, Afinitor receives US FDA approval FDA Approves mTOR Inhibitor Everolimus for Breast Cancer FDA approves Afinitor for Advanced Breast Cancer |
